This observation suggests that CDK inhibitor p21 acts as a barrier to the HIV infection of CD4+ T cells from ECs by inhibiting CDK9, a cellular co-factor for HIV viral Tat protein required for the efficient expression of HIV genes. Here, CD4 is linked to HIV infectious disease.